Adult Primary Hepatocellular Carcinoma Completed Phase 1 Trials for Sorafenib (DB00398)

Also known as: Primary Adult Hepatocellular Carcinoma

IndicationStatusPhase
DBCOND0029159 (Adult Primary Hepatocellular Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00844168Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver TransplantTreatment